Fasciola hepatica: Influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole
P. Sibille et al., Fasciola hepatica: Influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole, EXP PARASIT, 94(4), 2000, pp. 227-237
Two fasciolicide preparations have been compared in 130 rats experimentally
infected with Fasciola hepatica. Parasitological, immunological, and bioch
emical parameters have been followed to monitor the efficacy of the treatme
nts. While Fascinex (triclabendazole) efficiently cured both male and femal
e rats when administered as soon as 4 weeks postinfection, treatment with I
vomec-D (clorsulon + ivermectin) displayed a low efficacy on either male or
female rats at this time point (54 and 0%, respectively). Moreover, when a
dministered 8 weeks postinfection, the Ivomec-D treatment proved highly eff
icient on male rats while it displayed little effect on the female populati
on (100 and 53%, respectively). This unexpected result has been related to
an overexpression of a P4503A isoform that is observed only in females that
have been treated with Ivomec-D. The influence of this P4503A cytochrome o
n drug metabolism and the need for the incorporation of both genders in cli
nical trials are discussed. (C) 2000 Academic Press.